Our study was also limited by its small sample size, especially in the NAC exposed group, which precluded multi-level modeling of NAC responsiveness at various ANA titers and within IPF and IPAF disease states. The gene discussed is BTG3; the disease is idiopathic pulmonary fibrosis.